$76.83

+0.08 (+0.10%)

Weekly Expected Move ±3.5%

$69 $72 $74 $77 $79

NYSE · Healthcare · Medical - Care Facilities · Alpha Radar Strong Buy · Power 77 · $13.3B mcap · 147M float · 0.974% daily turnover · Short 66% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$8.3B +0.9% ▲

5Y CAGR: +2.7%

Gross Profit

$4.5B -3.1% ▼

5Y CAGR: +0.6%

Operating Income

$2.2B +110.5% ▲

5Y CAGR: +8.8%

Net Income

$1.6B +224.8% ▲

5Y CAGR: +6.5%

EPS (Diluted)

$8.88 +221.7% ▲

5Y CAGR: +6.1%

EBITDA

$2.5B +66.9% ▲

5Y CAGR: +4.7%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$8.2B	$8.1B	$8.2B	$8.3B	$8.3B
YoY Growth	+12.2%	-0.5%	+0.8%	+0.7%	+0.9%
Cost of Revenue	$3.2B	$3.4B	$3.5B	$3.7B	$3.9B
Gross Profit	$4.9B	$4.7B	$4.7B	$4.6B	$4.5B
Gross Margin	60.2%	57.7%	57.3%	55.6%	53.5%
R&D Expenses	$766M	$767M	$758M	$775M	$739M
SG&A Expenses	$2.3B	$2.2B	$2.2B	$2.8B	$3.1B
Operating Expenses	$3.0B	$3.0B	$3.0B	$3.6B	$2.3B
Operating Income	$1.9B	$1.7B	$1.7B	$1.0B	$2.2B
Operating Margin	23.0%	20.8%	20.6%	12.6%	26.2%
Interest Expense	$0	$0	$0	$367M	$347M
Income Before Tax	$1.9B	$1.7B	$1.7B	$605M	$1.7B
Tax Expense	$422M	$349M	$321M	$127M	$157M
Net Income	$1.5B	$1.3B	$1.3B	$479M	$1.6B
Net Margin	17.9%	16.5%	16.4%	5.8%	18.7%
EPS (Diluted)	$8.47	$7.79	$7.79	$2.76	$8.88
EBITDA	$2.5B	$2.3B	$2.2B	$1.5B	$2.5B
Shares Outstanding	172M	172M	173M	174M	175M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$2.1B	$2.1B	$2.1B	$2.1B	$2.2B	$2.1B	$2.0B	$2.0B
Cost of Revenue	$944M	$917M	$956M	$956M	$986M	$919M	$1.0B	$910M
Gross Profit	$1.1B	$1.2B	$1.1B	$1.1B	$1.2B	$1.2B	$985M	$1.1B
Gross Margin	54.6%	56.0%	53.9%	53.8%	54.4%	56.2%	49.3%	54.7%
R&D Expenses	$192M	$189M	$199M	$193M	$189M	$183M	$176M	$189M
SG&A Expenses	$701M	$701M	$784M	$769M	$772M	$780M	$759M	$827M
Operating Expenses	$893M	$890M	$983M	$962M	$961M	$1.0B	-$693M	$1.0B
Operating Income	$244M	$275M	$136M	$152M	$214M	$137M	$1.7B	$81M
Operating Margin	11.7%	13.2%	6.6%	7.3%	9.9%	6.5%	84.0%	4.0%
Interest Expense	$114M	$107M	$107M	$104M	$103M	$89M	$51M	$62M
Income Before Tax	$96M	$167M	$13M	$38M	$103M	$1.5B	$58M	$16M
Tax Expense	$7M	$45M	-$17M	-$99M	$13M	$248M	-$5M	$3M
Net Income	$89M	$122M	$31M	$137M	$90M	$1.3B	$63M	$13M
Net Margin	4.3%	5.9%	1.5%	6.6%	4.2%	60.4%	3.2%	0.6%
EPS (Diluted)	$0.51	$0.70	$0.18	$0.78	$0.51	$7.22	$0.37	$0.07
EBITDA	$343M	$407M	$270M	$271M	$328M	$1.7B	$489M	$216M
Shares Outstanding	174M	174M	174M	175M	175M	175M	175M	176M

SOLV NYSE